July 2017 Newsletter

July 20, 2017:

Ophthalmology Attracts $1.2 Billion in Investments in 26 Transactions During First Half of 2017

The amount was up more than 31 percent compared with the first half of 2016.

July 20, 2017:

OCTANe Summit Sees Big Data, Premium Procedures on Horizon for Ophthalmology

More than 300 industry leaders attended this year’s meeting.

July 20, 2017:

New Compounding Guidance Proves Divisive for Industry, Ophthalmologists

Mobius president is fighting a bill that would loosen FDA oversight, as doctors push for its passage.

July 20, 2017:

Beaver-Visitec Acquires Vitreq, Maker of Retinal Surgical Instruments

The move follows BVI’s purchase of Malosa Medical in April.

July 20, 2017:

Apple Buys SensoMotoric Instruments, Developer of Eye-Tracking Technology

The company’s technology served as the basis for Alcon’s Verion system.

July 20, 2017:

Ocular Therapeutix Receives Complete Response Letter for Resubmitted DEXTENZA NDA

The FDA found deficiencies in manufacturing processes and analytical testing during an inspection in May.

July 20, 2017:

Novartis’ RTH258 Successful in Two Phase III Studies for Wet AMD

A majority of patients were maintained on a 12-week dosing interval immediately following the loading phase through week 48.

July 20, 2017:

Alcon’s Clareon IOL Gains CE Marking

The company is hoping for US approval by 2019.

July 20, 2017:

Gottlieb Says US FDA to Expand Use of In Silico Clinical Trials

The move would bring the agency closer to industry, which has embraced the use of algorithmic science.

July 20, 2017:

US FDA Publishes List of Approved Drugs with No Generic Competition

The agency said it will update the list every six months.

July 20, 2017:

CMS Proposes ASC Facility Fee of $1,000.12 for Cataract Surgery in 2018

ASCs would receive a 1.9 percent inflation update, on average, in 2018, according to analysis by OOSS.

July 20, 2017:

Market Report: New Products Poised to Drive Glaucoma Pharma Market to $5.3 Billion by 2022

Alcon and Allergan are the market leaders; dozens of companies compete in the segment.

July 20, 2017:

Market Report: Glaucoma Surgical Device Market to Grow More than 28 Percent by 2022

MIGS implants will account for most of the growth over the next five years.

July 20, 2017:

Market Scope Weekly Polls

We asked surgeons what policies they would support related to drug pricing, as well as their plans for an EDOF ICL, if it becomes available.

July 20, 2017:

Alimera Seeks Uveitis Indication for Iluvien under Amended License with pSivida

The company said it plans to seek the added labeling in Europe within eight months.

July 20, 2017:

July 2017 News Briefs

Social media